Banque Cantonale Vaudoise Has $21.50 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Banque Cantonale Vaudoise trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 17.0% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 36,773 shares of the healthcare conglomerate's stock after selling 7,523 shares during the period. UnitedHealth Group makes up about 0.9% of Banque Cantonale Vaudoise's portfolio, making the stock its 14th biggest position. Banque Cantonale Vaudoise's holdings in UnitedHealth Group were worth $21,501,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently modified their holdings of the business. Kathleen S. Wright Associates Inc. acquired a new stake in shares of UnitedHealth Group in the 3rd quarter worth $27,000. Macroview Investment Management LLC increased its stake in shares of UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate's stock valued at $28,000 after purchasing an additional 47 shares in the last quarter. Bbjs Financial Advisors LLC purchased a new stake in UnitedHealth Group during the 2nd quarter worth approximately $31,000. Global Wealth Strategies & Associates increased its stake in UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate's stock worth $31,000 after buying an additional 32 shares in the last quarter. Finally, Signature Resources Capital Management LLC grew its position in shares of UnitedHealth Group by 40.0% in the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate's stock valued at $32,000 after purchasing an additional 18 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Down 2.1 %

NYSE:UNH traded down $12.65 during trading hours on Tuesday, hitting $577.00. 3,141,930 shares of the company's stock traded hands, compared to its average volume of 3,879,812. The firm has a market cap of $531.00 billion, a P/E ratio of 37.84, a P/E/G ratio of 1.74 and a beta of 0.58. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The stock's fifty day moving average price is $582.75 and its two-hundred day moving average price is $550.66.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same period in the prior year, the firm posted $6.56 EPS. The business's revenue was up 9.2% compared to the same quarter last year. On average, research analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be given a $2.10 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.46%. UnitedHealth Group's dividend payout ratio is currently 54.72%.

Analysts Set New Price Targets

A number of research analysts have commented on the company. Barclays decreased their price target on UnitedHealth Group from $604.00 to $603.00 and set an "overweight" rating on the stock in a research note on Tuesday, October 22nd. Royal Bank of Canada reduced their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an "outperform" rating for the company in a research report on Wednesday, October 16th. Bank of America cut their price target on UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating for the company in a report on Wednesday, October 16th. Hsbc Global Res lowered UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Thursday, October 17th. Finally, KeyCorp began coverage on UnitedHealth Group in a research note on Friday, October 11th. They set an "overweight" rating and a $675.00 price objective for the company. Three analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, UnitedHealth Group has an average rating of "Moderate Buy" and a consensus price target of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.